Expect significant selling pressure as warrant holders monetize positions, likely driving the stock toward the $2.075 warrant exercise price. Monitor trading volume for accelerated selling. The company's cash burn rate of ~$1.9M/quarter implies a runway of less than 6 months without additional capital, making further dilutive financing highly probable.
Price Chart
Executive Summary
Bluejay Diagnostics filed an S-3 registration statement to register 11,223,665 shares of common stock for resale by selling stockholders, representing shares issuable upon exercise of warrants from the June 2026 private placement. The company raised approximately $7.7 million net from the private placement but faces massive potential dilution of over 1,000% relative to the current 1.03 million shares outstanding, while remaining pre-revenue with a going concern risk and only $3.68 million in cash as of March 31, 2026.
Key Financial Metrics
Key Facts
- Registers 11,223,665 shares for resale by selling stockholders from June 2026 private placement warrants
- Company received ~$7.7M net proceeds from the private placement; will not receive proceeds from resale
- Current shares outstanding: 1,034,715 as of May 4, 2026 — potential dilution exceeds 1,000%
- Warrant exercise prices: Pre-funded at $0.0001, Series G/H at $2.075 per share; stock closed at $4.54 on June 16, 2026
- Company is pre-revenue with Q1 2026 net loss of $1.92M, cash of $3.68M, and accumulated deficit of $43.4M
- Expects to need at least $20M additional capital by end of 2027 to continue operations
Financial Impact
Potential dilution of over 1,000% from warrant exercises; company raised $7.7M net but faces severe overhang
Risk Factors
- Massive dilution from warrant exercises could crush stock price
- Going concern risk with only $3.68M cash and no revenue
- Need for additional capital beyond current raise — at least $20M by 2027
- Nasdaq listing compliance risk after four reverse stock splits since 2023
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 8 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| S-3 Filing (Primary) | 0001213900-26-069727 |
| Document: ea029488901ex10-3.htm | 0001213900-26-069727 |
| Document: ea029488901ex-fee.htm | 0001213900-26-069727 |
| Document: ea029488901ex5-1.htm | 0001213900-26-069727 |
| Document: ea029488901ex23-1.htm | 0001213900-26-069727 |
| Document: 0001213900-26-069727-index-headers.html | 0001213900-26-069727 |
| Document: 0001213900-26-069727-index.html | 0001213900-26-069727 |
| Document: 0001213900-26-069727.txt | 0001213900-26-069727 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 13, 2026 14d ago | 8-K | $0.8323 | awaiting T+20 | — | $0.5771 (−30.66%) |
Oct 6, 2026 21d ago | 8-K | $0.8107 | awaiting T+20 | — | $0.5771 (−28.81%) |
Aug 13, 2026 10w ago | 8-K | $1.06 | awaiting T+20 | — | $0.5771 (−45.56%) |
Aug 13, 2026 10w ago | Press Release | $1.06 | awaiting T+20 | — | $0.5771 (−45.56%) |
Jul 22, 2026 13w ago | 8-K | $1.14 $0.9393 | ▼ −17.61% | ▼ −20.91% | $0.5771 (−49.38%) |
Jul 13, 2026 15w ago | 3 | $1.22 $0.9872 | ▼ −19.08% | ▼ −22.27% | $0.5771 (−52.70%) |
Jul 10, 2026 15w ago | 3 | $1.45 $1.07 | ▼ −26.21% | ▼ −28.63% | $0.5771 (−60.20%) |
Jun 29, 2026 17w ago | EFFECT | $1.44 $1.03 | ▲ +28.47% | ▲ +28.19% | $0.5771 (+59.92%) |
Jun 17, 2026 18w ago | S-3 | $4.46 $1.30 | ▲ +70.85% | ▲ +71.39% | $0.5771 (+87.06%) |
Jun 9, 2026 20w ago | 8-K | $4.49 $1.40 | ▼ −68.82% | ▼ −72.44% | $0.5771 (−87.15%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers